David Myles
Corporate Officer/Principal chez OLEMA PHARMACEUTICALS, INC.
Fortune : 8 M $ au 31/03/2024
Profil
David C.
Myles was the founder of Epiphany Biosciences, Inc. (founded in 2006) where he held the title of Chief Operating Officer from 2006 to 2008.
He currently holds the position of Chairman-Finance at Point Blue Conservation Science, Trustee at The Webb School of California, and Chief Discovery & Non-Clinical Development Officer at Olema Pharmaceuticals, Inc. Dr. Myles previously worked as Associate Director-Medical Chemistry at Chiron Corp.
from 1998 to 2001, Executive Director-Chemistry at Kosan Biosciences, Inc. from 2006 to 2007, and Assistant Professor at the University of California, Los Angeles from 1991 to 1998.
He obtained a doctorate degree from Yale University in 1989 and also holds an undergraduate degree from Occidental College.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 01/02/2024 | 741 776 ( 1,33% ) | 8 M $ | 31/03/2024 |
Postes actifs de David Myles
| Sociétés | Poste | Début |
|---|---|---|
| OLEMA PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/04/2008 |
The Webb School of California
 The Webb School of California Other Consumer ServicesConsumer Services The Webb School of California was founded in 1880 and is based in Claremont, CA. The school offers a college preparatory boarding and day high school experience with an unbounded curriculum and cultural and environmental assets. | Director/Board Member | - |
| Point Blue Conservation Science | Director of Finance/CFO | - |
Anciens postes connus de David Myles
| Sociétés | Poste | Fin |
|---|---|---|
Epiphany Biosciences, Inc.
 Epiphany Biosciences, Inc. Medical SpecialtiesHealth Technology Epiphany Biosciences, Inc. develops therapeutic products and diagnostic technologies that treat and prevent the spread of pathogenic viruses. The firm develops therapeutics to prevent spread of varicella zoster virus (VZV), Epstein-Barr virus (EBV), and hepatitis C virus (HCV). The company was founded by David C Myles, Robert Charles Gallo, Harold E Selick and Frederick Volinsky in 2001 and is headquartered in San Francisco, CA. | Founder | 01/01/2008 |
Kosan Biosciences, Inc.
 Kosan Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Kosan Biosciences, Inc. develops drugs for cancer therapeutics. The company was founded in 1995 and is headquartered in New York, NY. | Corporate Officer/Principal | 01/11/2007 |
Chiron Corp.
 Chiron Corp. Medical SpecialtiesHealth Technology Chiron Corp. provides nucleic acid test for blood screening. Its products include tigris system, target capture system, reagent preparation incubator, and many more. The company was founded in 1981 by William J. Rutter, Edward E. Penhoet & Pablo Valenzuela and is headquartered in Emeryville, CA. | Corporate Officer/Principal | 01/01/2001 |
| University of California, Los Angeles | Corporate Officer/Principal | 01/01/1998 |
Formation de David Myles
| Yale University | Doctorate Degree |
| Occidental College | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| OLEMA PHARMACEUTICALS, INC. | Health Technology |
| Entreprise privées | 5 |
|---|---|
Chiron Corp.
Chiron Corp. Medical SpecialtiesHealth Technology Chiron Corp. provides nucleic acid test for blood screening. Its products include tigris system, target capture system, reagent preparation incubator, and many more. The company was founded in 1981 by William J. Rutter, Edward E. Penhoet & Pablo Valenzuela and is headquartered in Emeryville, CA. | Health Technology |
Kosan Biosciences, Inc.
Kosan Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Kosan Biosciences, Inc. develops drugs for cancer therapeutics. The company was founded in 1995 and is headquartered in New York, NY. | Health Technology |
Epiphany Biosciences, Inc.
Epiphany Biosciences, Inc. Medical SpecialtiesHealth Technology Epiphany Biosciences, Inc. develops therapeutic products and diagnostic technologies that treat and prevent the spread of pathogenic viruses. The firm develops therapeutics to prevent spread of varicella zoster virus (VZV), Epstein-Barr virus (EBV), and hepatitis C virus (HCV). The company was founded by David C Myles, Robert Charles Gallo, Harold E Selick and Frederick Volinsky in 2001 and is headquartered in San Francisco, CA. | Health Technology |
The Webb School of California
The Webb School of California Other Consumer ServicesConsumer Services The Webb School of California was founded in 1880 and is based in Claremont, CA. The school offers a college preparatory boarding and day high school experience with an unbounded curriculum and cultural and environmental assets. | Consumer Services |
| Point Blue Conservation Science |
